Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
FELE Quote, Financials, Valuation and Earnings
Last price:
$91.56
Seasonality move
:
4.25%
Day range:
$89.57 - $92.02
52-week range:
$78.87 - $111.94
Dividend yield:
1.13%
P/E ratio:
23.97x
P/S ratio:
2.10x
P/B ratio:
3.22x
Volume:
189.9K
Avg. volume:
287.1K
1-year change:
-12.25%
Market cap:
$4.2B
Revenue:
$2B
EPS (TTM):
$3.82
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.7B | $2B | $2.1B | $2B | |
| Revenue Growth (YoY) | -5.12% | 33.23% | 22.98% | 1.05% | -2.12% | |
| Cost of Revenues | $814.2M | $1.1B | $1.4B | $1.4B | $1.3B | |
| Gross Profit | $433.1M | $576.1M | $691.4M | $697M | $717.3M | |
| Gross Profit Margin | 34.73% | 34.67% | 33.83% | 33.75% | 35.49% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $300.1M | $386.3M | $432.1M | $433.5M | $470.1M | |
| Other Inc / (Exp) | -$4.7M | $5.1M | -$12.6M | -$9.5M | -$9M | |
| Operating Expenses | $300.1M | $386.3M | $432.1M | $433.5M | $470.1M | |
| Operating Income | $133M | $189.8M | $259.4M | $263.5M | $247.1M | |
| Net Interest Expenses | $4.6M | $5.2M | $11.5M | $11.8M | $6.3M | |
| EBT. Incl. Unusual Items | $123.7M | $189.7M | $235.2M | $242.2M | $231.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22.5M | $34.7M | $46.4M | $47.5M | $50.2M | |
| Net Income to Company | $101.2M | $155M | $188.8M | $194.7M | $181.6M | |
| Minority Interest in Earnings | -$697K | -$1.1M | -$1.5M | -$1.5M | -$1.3M | |
| Net Income to Common Excl Extra Items | $100.5M | $153.9M | $187.3M | $193.3M | $180.3M | |
| Basic EPS (Cont. Ops) | $2.16 | $3.29 | $4.02 | $4.17 | $3.92 | |
| Diluted EPS (Cont. Ops) | $2.14 | $3.25 | $3.97 | $4.11 | $3.86 | |
| Weighted Average Basic Share | $46.2M | $46.4M | $46.3M | $46.2M | $45.9M | |
| Weighted Average Diluted Share | $46.7M | $47M | $47M | $46.9M | $46.5M | |
| EBITDA | $164.8M | $239.5M | $297.1M | $306.3M | $294.2M | |
| EBIT | $128.3M | $194.9M | $246.8M | $254M | $238.2M | |
| Revenue (Reported) | $1.2B | $1.7B | $2B | $2.1B | $2B | |
| Operating Income (Reported) | $133M | $189.8M | $259.4M | $263.5M | $247.1M | |
| Operating Income (Adjusted) | $128.3M | $194.9M | $246.8M | $254M | $238.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $333M | $451.5M | $484.6M | $460.9M | $455.2M | |
| Revenue Growth (YoY) | 24.85% | 35.56% | 7.33% | -4.88% | -1.23% | |
| Cost of Revenues | $217.5M | $306.1M | $322.3M | $297.3M | $291.3M | |
| Gross Profit | $115.5M | $145.3M | $162.3M | $163.6M | $163.9M | |
| Gross Profit Margin | 34.69% | 32.19% | 33.49% | 35.49% | 36% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $81.6M | $104.7M | $109.5M | $115.6M | $119.6M | |
| Other Inc / (Exp) | -$309K | -$1.7M | -$1.8M | -$4.2M | -$609K | |
| Operating Expenses | $81.6M | $104.7M | $109.5M | $115.6M | $119.6M | |
| Operating Income | $33.9M | $40.7M | $52.7M | $47.9M | $44.3M | |
| Net Interest Expenses | $1.1M | $1.5M | $3.1M | $1.4M | $1.8M | |
| EBT. Incl. Unusual Items | $32.5M | $37.5M | $47.8M | $42.3M | $41.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.4M | $7.4M | $10.2M | $9.2M | $10.5M | |
| Net Income to Company | $28.2M | $30.1M | $37.6M | $33.1M | $31.4M | |
| Minority Interest in Earnings | -$283K | -$354K | -$251K | -$133K | -$412K | |
| Net Income to Common Excl Extra Items | $27.9M | $29.8M | $37.3M | $33M | $31M | |
| Basic EPS (Cont. Ops) | $0.60 | $0.64 | $0.81 | $0.71 | $0.67 | |
| Diluted EPS (Cont. Ops) | $0.59 | $0.63 | $0.79 | $0.70 | $0.67 | |
| Weighted Average Basic Share | $46.3M | $46.4M | $46.2M | $46.1M | $45.7M | |
| Weighted Average Diluted Share | $46.9M | $47.1M | $46.9M | $46.7M | $46.3M | |
| EBITDA | $43.2M | $51.1M | $63.8M | $57.6M | $58.1M | |
| EBIT | $33.6M | $39M | $51M | $43.8M | $43.7M | |
| Revenue (Reported) | $333M | $451.5M | $484.6M | $460.9M | $455.2M | |
| Operating Income (Reported) | $33.9M | $40.7M | $52.7M | $47.9M | $44.3M | |
| Operating Income (Adjusted) | $33.6M | $39M | $51M | $43.8M | $43.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.8B | $2.1B | $2B | $2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $855.3M | $1.2B | $1.4B | $1.3B | $1.3B | |
| Gross Profit | $458.4M | $605.9M | $708.4M | $698.3M | $717.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $306.1M | $409.3M | $436.9M | $439.6M | $474.1M | |
| Other Inc / (Exp) | -$4.9M | $3.7M | -$12.7M | -$11.9M | -$5.4M | |
| Operating Expenses | $306.1M | $409.3M | $436.9M | $439.6M | $474.1M | |
| Operating Income | $152.3M | $196.5M | $271.4M | $258.7M | $243.5M | |
| Net Interest Expenses | $4.5M | $5.6M | $13.2M | $10.1M | $6.7M | |
| EBT. Incl. Unusual Items | $142.9M | $194.6M | $245.6M | $236.7M | $231.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24.4M | $37.7M | $49.3M | $46.5M | $51.5M | |
| Net Income to Company | $118.5M | $156.9M | $196.3M | $190.3M | $179.9M | |
| Minority Interest in Earnings | -$831K | -$1.2M | -$1.4M | -$1.3M | -$1.6M | |
| Net Income to Common Excl Extra Items | $117.7M | $155.7M | $194.9M | $188.9M | $178.3M | |
| Basic EPS (Cont. Ops) | $2.53 | $3.34 | $4.19 | $4.08 | $3.87 | |
| Diluted EPS (Cont. Ops) | $2.50 | $3.29 | $4.13 | $4.02 | $3.82 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $184.2M | $247.3M | $309.9M | $300M | $294.8M | |
| EBIT | $147.4M | $200.2M | $258.7M | $246.8M | $238.1M | |
| Revenue (Reported) | $1.3B | $1.8B | $2.1B | $2B | $2B | |
| Operating Income (Reported) | $152.3M | $196.5M | $271.4M | $258.7M | $243.5M | |
| Operating Income (Adjusted) | $147.4M | $200.2M | $258.7M | $246.8M | $238.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $333M | $451.5M | $484.6M | $460.9M | $455.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $217.5M | $306.1M | $322.3M | $297.3M | $291.3M | |
| Gross Profit | $115.5M | $145.3M | $162.3M | $163.6M | $163.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $81.6M | $104.7M | $109.5M | $115.6M | $119.6M | |
| Other Inc / (Exp) | -$309K | -$1.7M | -$1.8M | -$4.2M | -$609K | |
| Operating Expenses | $81.6M | $104.7M | $109.5M | $115.6M | $119.6M | |
| Operating Income | $33.9M | $40.7M | $52.7M | $47.9M | $44.3M | |
| Net Interest Expenses | $1.1M | $1.5M | $3.1M | $1.4M | $1.8M | |
| EBT. Incl. Unusual Items | $32.5M | $37.5M | $47.8M | $42.3M | $41.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.4M | $7.4M | $10.2M | $9.2M | $10.5M | |
| Net Income to Company | $28.2M | $30.1M | $37.6M | $33.1M | $31.4M | |
| Minority Interest in Earnings | -$283K | -$354K | -$251K | -$133K | -$412K | |
| Net Income to Common Excl Extra Items | $27.9M | $29.8M | $37.3M | $33M | $31M | |
| Basic EPS (Cont. Ops) | $0.60 | $0.64 | $0.81 | $0.71 | $0.67 | |
| Diluted EPS (Cont. Ops) | $0.59 | $0.63 | $0.79 | $0.70 | $0.67 | |
| Weighted Average Basic Share | $46.3M | $46.4M | $46.2M | $46.1M | $45.7M | |
| Weighted Average Diluted Share | $46.9M | $47.1M | $46.9M | $46.7M | $46.3M | |
| EBITDA | $43.2M | $51.1M | $63.8M | $57.6M | $58.1M | |
| EBIT | $33.6M | $39M | $51M | $43.8M | $43.7M | |
| Revenue (Reported) | $333M | $451.5M | $484.6M | $460.9M | $455.2M | |
| Operating Income (Reported) | $33.9M | $40.7M | $52.7M | $47.9M | $44.3M | |
| Operating Income (Adjusted) | $33.6M | $39M | $51M | $43.8M | $43.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $130.8M | $40.5M | $45.8M | $85M | $220.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $159.8M | $196.2M | $230.4M | $222.4M | $226.8M | |
| Inventory | $300.9M | $450M | $545M | $508.7M | $483.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $27.7M | $38M | $36.9M | $37.7M | $33M | |
| Total Current Assets | $619.3M | $724.6M | $858.1M | $853.8M | $964.2M | |
| Property Plant And Equipment | $241M | $259M | $264.1M | $286.8M | $286.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $266.7M | $329.6M | $328M | $342.4M | $338.5M | |
| Other Intangibles | $133.8M | $249.7M | $231.3M | $230M | $213M | |
| Other Long-Term Assets | $2.7M | $4.5M | $5.9M | $6.4M | $10.5M | |
| Total Assets | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Accounts Payable | $95.9M | $164.8M | $139.3M | $152.4M | $157M | |
| Accrued Expenses | $48.5M | $75.1M | $70.8M | $57.7M | $60.4M | |
| Current Portion Of Long-Term Debt | $2.6M | $98M | $126.8M | $12.4M | $117.8M | |
| Current Portion Of Capital Lease Obligations | $11.1M | $15.3M | $16M | $17.3M | $18.9M | |
| Other Current Liabilities | $30.7M | $28.4M | $36.3M | $28.7M | $39.5M | |
| Total Current Liabilities | $203.7M | $396M | $405.8M | $287M | $433.7M | |
| Long-Term Debt | $92M | $90.5M | $89.3M | $88.1M | $11.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $422.4M | $626.5M | $623.4M | $517.8M | $550.8M | |
| Common Stock | $4.6M | $4.6M | $4.6M | $4.6M | $4.6M | |
| Other Common Equity Adj | -$204.8M | -- | -- | -$221.1M | -$254M | |
| Common Equity | $847.8M | $946.5M | $1.1B | $1.2B | $1.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.1M | $2.1M | $2.9M | $3.6M | $3.7M | |
| Total Equity | $849.9M | $948.6M | $1.1B | $1.2B | $1.3B | |
| Total Liabilities and Equity | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Cash and Short Terms | $130.8M | $40.5M | $45.8M | $85M | $220.5M | |
| Total Debt | $94.5M | $188.5M | $216M | $100.4M | $129.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $118.3M | $38.6M | $51.9M | $65.3M | $84M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $179.4M | $229.7M | $276.5M | $262.6M | $271.7M | |
| Inventory | $310.3M | $527.9M | $600.7M | $532.2M | $560.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $27.2M | $37.4M | $39M | $41.2M | $40.6M | |
| Total Current Assets | $635.3M | $833.6M | $968M | $901.4M | $956.6M | |
| Property Plant And Equipment | $238.6M | $260.6M | $266.2M | $288.1M | $297M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $265.3M | $329.4M | $329.3M | $340.5M | $391.5M | |
| Other Intangibles | $130.3M | $247.1M | $227.2M | $226.7M | $260.8M | |
| Other Long-Term Assets | $2.9M | $4.8M | $5.7M | $6.7M | $15.2M | |
| Total Assets | $1.3B | $1.7B | $1.8B | $1.8B | $1.9B | |
| Accounts Payable | $110M | $190.5M | $188M | $185.5M | $190.3M | |
| Accrued Expenses | $68.8M | $52M | $48.1M | $44.6M | $47.8M | |
| Current Portion Of Long-Term Debt | $2.7M | $194.8M | $185.3M | $24.4M | $149.7M | |
| Current Portion Of Capital Lease Obligations | $11.8M | $15.2M | $15.1M | $18M | $18.7M | |
| Other Current Liabilities | -- | $29.6M | $34.6M | $25.7M | $38.1M | |
| Total Current Liabilities | $200.4M | $491.6M | $486.9M | $316.2M | $484M | |
| Long-Term Debt | $91.4M | $89.9M | $88.8M | $87.4M | $14.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $418M | $719M | $707.8M | $549M | $627.6M | |
| Common Stock | $4.6M | $4.6M | $4.6M | $4.6M | $4.6M | |
| Other Common Equity Adj | -$215.3M | -$219M | -- | -$227.9M | -$240.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.3M | $2.5M | $3.2M | $3.7M | $4M | |
| Total Equity | $863.7M | $964.2M | $1.1B | $1.2B | $1.3B | |
| Total Liabilities and Equity | $1.3B | $1.7B | $1.8B | $1.8B | $1.9B | |
| Cash and Short Terms | $118.3M | $38.6M | $51.9M | $65.3M | $84M | |
| Total Debt | $94M | $284.8M | $274M | $111.8M | $164.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $101.2M | $155M | $188.8M | $194.7M | $181.6M | |
| Depreciation & Amoritzation | $36.5M | $44.6M | $50.4M | $52.3M | $56.1M | |
| Stock-Based Compensation | $10.1M | $11.7M | $11M | $10.1M | $12.1M | |
| Change in Accounts Receivable | $22.1M | -$31.9M | -$44.8M | $19.2M | -$17M | |
| Change in Inventories | $13.1M | -$123.1M | -$101.1M | $48.2M | $10.9M | |
| Cash From Operations | $211.9M | $129.8M | $101.7M | $315.7M | $261.4M | |
| Capital Expenditures | $22.9M | $30.1M | $41.9M | $41.4M | $41.7M | |
| Cash Acquisitions | -$55.9M | -$235.7M | -$1.2M | -$34.8M | -$5.2M | |
| Cash From Investing | -$78.8M | -$264.8M | -$43.1M | -$74.3M | -$45.6M | |
| Dividends Paid (Ex Special Dividend) | -$29.7M | -$33.4M | -$37M | -$41.7M | -$46.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $117.8M | $321.3M | $477.6M | $443.2M | $309.7M | |
| Long-Term Debt Repaid | -$138.8M | -$226.6M | -$448.6M | -$558.7M | -$280.5M | |
| Repurchase of Common Stock | -$19.6M | -$25.9M | -$40.5M | -$43.3M | -$61M | |
| Other Financing Activities | -- | -- | -$3.8M | -$802K | -$2.6M | |
| Cash From Financing | -$66.6M | $50.9M | -$48.5M | -$192.2M | -$74.1M | |
| Beginning Cash (CF) | $64.4M | $130.8M | $40.5M | $45.8M | $85M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $66.5M | -$84.1M | $10.1M | $49.2M | $141.7M | |
| Ending Cash (CF) | $130.8M | $40.5M | $45.8M | $85M | $220.5M | |
| Levered Free Cash Flow | $189M | $99.6M | $59.8M | $274.3M | $219.7M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $39.4M | $59.8M | $60.2M | $59.3M | -- | |
| Depreciation & Amoritzation | $11M | $12.4M | $13.4M | $13.9M | -- | |
| Stock-Based Compensation | $2.4M | $2.3M | $2.5M | $3M | -- | |
| Change in Accounts Receivable | -$38.7M | -$58.9M | -$27.3M | -$39.5M | -- | |
| Change in Inventories | -$27.5M | -$49.1M | $26.6M | $4.1M | -- | |
| Cash From Operations | $30.1M | -$1.2M | $55M | $36.4M | -- | |
| Capital Expenditures | $6M | $10.6M | $10.7M | $10.3M | -- | |
| Cash Acquisitions | -$181M | -$1.9M | -$1.7M | -- | -- | |
| Cash From Investing | -$187M | -$12.5M | -$12.3M | -$9.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -$8.2M | -$9.1M | -$10.4M | -$11.6M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $149.7M | $143.3M | $153M | $139.5M | -- | |
| Long-Term Debt Repaid | -$19.9M | -$113.8M | -$178.5M | -$121.7M | -- | |
| Repurchase of Common Stock | -$6.4M | -$11.3M | -$8.4M | -$38.8M | -- | |
| Other Financing Activities | -- | -- | -$186K | -- | -- | |
| Cash From Financing | $119.1M | $10.6M | -$38.5M | -$32.4M | -- | |
| Beginning Cash (CF) | $118.3M | $38.6M | $51.9M | $65.3M | -- | |
| Foreign Exchange Rate Adjustment | $1M | -$2.2M | -$2.8M | -$1.2M | -- | |
| Additions / Reductions | -$37.8M | -$3.2M | $4.2M | -$6M | -- | |
| Ending Cash (CF) | $81.6M | $33.2M | $53.2M | $58.1M | -- | |
| Levered Free Cash Flow | $24.1M | -$11.9M | $44.4M | $26.1M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $118.5M | $156.9M | $196.3M | $190.3M | $179.9M | |
| Depreciation & Amoritzation | $36.9M | $47.1M | $51.1M | $53.2M | $56.7M | |
| Stock-Based Compensation | $9.9M | $11.5M | $10.9M | $10.3M | $13M | |
| Change in Accounts Receivable | $431K | -$41.8M | -$54.1M | $19.2M | -$3.1M | |
| Change in Inventories | $18.8M | -$183.4M | -$77.1M | $70.8M | -$4.7M | |
| Cash From Operations | $221.9M | $63.1M | $151M | $326.4M | $243.2M | |
| Capital Expenditures | $24.1M | $32.8M | $42M | $41M | $39.3M | |
| Cash Acquisitions | -$50.2M | -$235.2M | -$6.7M | -$31M | -$113.7M | |
| Cash From Investing | -$74.3M | -$267M | -$48.7M | -$70M | -$151.5M | |
| Dividends Paid (Ex Special Dividend) | -$30.6M | -$34.4M | -$38.3M | -$43.7M | -$47.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $61.8M | $519.2M | $420.7M | $387.1M | $260.8M | |
| Long-Term Debt Repaid | -$103M | -$327.1M | -$430.9M | -$549M | -$222.6M | |
| Repurchase of Common Stock | -$7.4M | -$40.4M | -$38.3M | -$35.2M | -$58.9M | |
| Other Financing Activities | -- | -- | -- | -$1.2M | -$6.5M | |
| Cash From Financing | -$71.3M | $128M | -$84.1M | -$231.6M | -$70.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $76.3M | -$76M | $18.1M | $24.8M | $21.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $197.8M | $30.2M | $109M | $285.3M | $203.9M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $67.5M | $89.9M | $97.7M | $92.4M | $31.4M | |
| Depreciation & Amoritzation | $20.5M | $24.5M | $26.3M | $27.7M | $14.4M | |
| Stock-Based Compensation | $6.6M | $6.3M | $6.4M | $7M | $5M | |
| Change in Accounts Receivable | -$62.9M | -$93.1M | -$70.7M | -$82.8M | -$29.4M | |
| Change in Inventories | -$41.8M | -$123.8M | -$24.1M | -$24M | -$43.7M | |
| Cash From Operations | $35.5M | -$62.5M | $43M | $35M | -$19.5M | |
| Capital Expenditures | $12.8M | $20.1M | $20.2M | $19.4M | $6.8M | |
| Cash Acquisitions | -$180.9M | -$1.4M | -$6.6M | -$1.2M | -$109.7M | |
| Cash From Investing | -$193.7M | -$21.5M | -$26.9M | -$20.2M | -$116.1M | |
| Dividends Paid (Ex Special Dividend) | -$16.3M | -$18.2M | -$20.9M | -$24M | -$13.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $150.3M | $341.8M | $294.7M | $225M | $36.6M | |
| Long-Term Debt Repaid | -$21.1M | -$215.5M | -$262.5M | -$195.9M | -$16.3M | |
| Repurchase of Common Stock | -$11.2M | -$30.6M | -$25.5M | -$47.9M | -$6.9M | |
| Other Financing Activities | -- | -- | -$186K | -$348K | -$4.3M | |
| Cash From Financing | $110.7M | $79.3M | -$5.4M | -$38.7M | -$2.6M | |
| Beginning Cash (CF) | $249.1M | $79.1M | $97.7M | $150.3M | $220.5M | |
| Foreign Exchange Rate Adjustment | -$1.8M | -$2.7M | -$3.3M | -$3M | $1.6M | |
| Additions / Reductions | -$47.4M | -$4.7M | $10.7M | -$23.9M | -$138.1M | |
| Ending Cash (CF) | $199.9M | $71.8M | $105.1M | $123.4M | $84M | |
| Levered Free Cash Flow | $22.8M | -$82.6M | $22.8M | $15.6M | -$26.3M | |
Get FELE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FELE
Sector
P/E ratio
23.97x
18.58x
PEG ratio
--
0.25x
P/B ratio
3.22x
1.75x
Price / LTM sales
2.10x
0.94x
Growth Metrics
FELE
Sector
Revenue growth
-1.23%
1.98%
Earnings growth
-4.29%
2.46%
Revenue (5-year growth)
8.99%
4.35%
Earnings forecast
$1.29
$0.40
Profitability
FELE
Sector
Profitability FY 2024
$717.3M
$393.9M
Return on invested capital
12.89%
5.32%
Return on assets
9.78%
3.49%
Return on equity
14.16%
8.55%
Earnings Date
Last Earnings Date
Apr
29
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Jul
29
Balance Sheet
FELE
Sector
Total cash
$84M
$154.3M
Short term investments
--
$35.5M
Total assets
$1.8B
$1.7B
Long term debt
$164.6M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
